Ever Fortune.AI Co (ROCO:6841) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6841 Ever Fortune.AI Co Ltd ROCO:6841
76 GF Score
Price NT$63.50
GF Value NT$218.19
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ever Fortune.AI Co FFO?

FFO (Funds from operations) only applies to REITs.

ROCO:6841
76GF Score
Ever Fortune.AI Co Ltd ROCO:6841
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ever Fortune.AI Co (ROCO:6841) Overvalued in 2026?

Based on GuruFocus' analysis, Ever Fortune.AI Co stock appears to be undervalued. The current stock price of NT$63.50 is trading 70.9% below its estimated GF Value™ of NT$218.19. GuruFocus considers Ever Fortune.AI Co to be Significantly Undervalued.

Key valuation signals for ROCO:6841:

  • FFO:
  • GF Value™: NT$218.19 vs. price of NT$63.50 (70.9% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6841 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ever Fortune.AI Co Business Description

Address Jingmao Road, 8th Floor, No. 360, Section 1, Beitun District, Taichung, TWN, 406040
Ever Fortune.AI Co Ltd is composed of establishing a cloud medical platform based on medical Big data, and to provide customized medical artificial intelligence solutions and services in various biomedical fields. The results both provide a professional second opinion for doctors and assist clinical doctors in making a medical diagnosis, which in turn raises the speed, accuracy, and efficiency of medical decisions. The products of the company include: Medical Artificial Intelligence, Cloud Biomedical Platform, and Medical Big Data. Its segments are: Medical AI Department; Biotechnology Department; and Others, where maximum revenue is derived from Biotechnology Department segment. Geographically, it operates in Taiwan, U.S.A., and Vietnam, of which maximum revenue is generated from Taiwan.
76GF Score

Get the complete analysis for ROCO:6841

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.50
Price
NT$218.19
GF Value